Furthermore, PIN1 inhibition mediated by ATRA induces the degradation of PML-RARA oncoprotein, resulting in anti-proliferative effect in APL cells and mouse models, as well as in humans. The gene discussed is PIN1; the disease is acute promyelocytic leukemia.